Your browser doesn't support javascript.
loading
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.
Alhalabi, Omar; Zhu, Yueting; Hamza, Ameer; Qiao, Wei; Lin, Yiyun; Wang, Raymond M; Shah, Amishi Y; Campbell, Matthew T; Holla, Vijaykumar; Kamat, Ashish; Wang, Wei-Lien; Wang, Jennifer; Chen, Jianfeng; Meng, Jieru; Zhang, Miao; Bondaruk, Jolanta; Titus, Mark; Genovese, Giannicola; Czerniak, Bogdan A; Shaw, Kenna R; Meric-Bernstam, Funda; Guo, Charles C; Logothetis, Christopher J; Siefker-Radtke, Arlene; Msaouel, Pavlos; Wang, Linghua; Liu, Jiyan; Gao, Jianjun.
Afiliación
  • Alhalabi O; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: oalhalabi@mdanderson.org.
  • Zhu Y; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Biotherapy, Cancer Center and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Hamza A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lin Y; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang RM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kamat A; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Meng J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bondaruk J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Genovese G; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Czerniak BA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shaw KR; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Siefker-Radtke A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Msaouel P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang L; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu J; Department of Biotherapy, Cancer Center and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Gao J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jgao1@mdanderson.org.
Eur Urol Oncol ; 6(2): 228-232, 2023 04.
Article en En | MEDLINE | ID: mdl-34789422
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article